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Human Rhinovirus 16 Causes Golgi Apparatus Fragmentation without
Blocking Protein Secretion
Aurelie Mousnier, Dawid Swieboda, Anaïs Pinto,* Anabel Guedán, Andrew V. Rogers,* Ross Walton, Sebastian L. Johnston,
Roberto Solari
Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, United Kingdom
ABSTRACT
The replication of picornaviruses has been described to cause fragmentation of the Golgi apparatus that blocks the secretory
pathway. The inhibition of major histocompatibility complex class I upregulation and cytokine, chemokine and interferon se-
cretionmay have important implications for host defense. Previous studies have shown that disruption of the secretory pathway
can be replicated by expression of individual nonstructural proteins; however the situation with different serotypes of human
rhinovirus (HRV) is unclear. The expression of 3A protein fromHRV14 or HRV2 did not cause Golgi apparatus disruption or a
block in secretion, whereas other studies showed that infection of cells with HRV1A did cause Golgi apparatus disruption which
was replicated by the expression of 3A. HRV16 is the serotype most widely used in clinical HRV challenge studies; consequently,
to address the issue of Golgi apparatus disruption for HRV16, we have systematically and quantitatively examined the effect of
HRV16 on both Golgi apparatus fragmentation and protein secretion in HeLa cells. First, we expressed each individual non-
structural protein and examined their cellular localization and their disruption of endoplasmic reticulum and Golgi apparatus
architecture. We quantified their effects on the secretory pathway by measuring secretion of the reporter protein Gaussia lucifer-
ase. Finally, we examined the same outcomes following infection of cells with live virus. We demonstrate that expression of
HRV16 3A and 3AB and, to a lesser extent, 2B caused dispersal of the Golgi structure, and these three nonstructural proteins also
inhibited protein secretion. The infection of cells with HRV16 also caused significant Golgi apparatus dispersal; however, this
did not result in the inhibition of protein secretion.
IMPORTANCE
The ability of replicating picornaviruses to influence the function of the secretory pathway has important implications for host
defense. However, there appear to be differences between different members of the family and inconsistent results when com-
paring infection with live virus to expression of individual nonstructural proteins. We demonstrate that individual nonstruc-
tural HRV16 proteins, when expressed in HeLa cells, can both fragment the Golgi apparatus and block secretion, whereas viral
infection fragments the Golgi apparatus without blocking secretion. This has major implications for how we interpret mechanis-
tic evidence derived from the expression of single viral proteins.
Viral respiratory tract infections represent a major health careburden, with an estimated 500 million cases and a cost of $40
billion per year in the United States alone (1). It has been sus-
pected since the 1970s that respiratory viral infections are a major
trigger for asthma exacerbations in children and adults (2, 3), and
with the development ofmore sensitive and specific diagnostics, it
is clear now that around 80% of wheezing episodes in school-aged
children and between half to three-quarters of wheezing in adults
can be attributed to respiratory viral infections. Although there
are a number of viruses implicated, rhinoviruses (HRVs) are the
most frequently detected pathogens and are found in 65% of
these cases (4–8). HRV infection also is known to be a major
contributory factor in exacerbations of chronic obstructive pul-
monary disease (COPD) (9–11).
HRVs are members of the positive-sense single-strand RNA
Picornaviridae family, for which the best studied prototype is po-
liovirus (PV) andwhich includes other important pathogens, such
as foot-and-mouth disease virus (FMDV), hepatitis A virus, and
coxsackie virus (CV). Upon entering a host cell, the RNA genome
of these viruses is translated into a polyprotein that is posttransla-
tionally cleaved by the encoded viral proteases to generate the
structural and nonstructural proteins required for viral replica-
tion. The developing virus forms replication complexes on the
surface of intracellular membranes, believed to be derived either
from the endoplasmic reticulum (ER)/Golgi secretory appara-
tus or from autophagosomes, and greatly remodels their mor-
phology and lipid composition (12). For those viruses where it
has been studied, the viral proteins 2B, 2C, and 3A and the
intermediates 2BC and 3AB have been shown to be membrane
associated, and these membranous replication complexes have
been investigated intensely by microscopy, molecular, and bio-
chemical studies (13, 14).
Although picornaviruses share a replication strategy, there ap-
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pears to be significant and important differences between picor-
naviruses. The different techniques used to study them have not
always generated consistent results. Picornavirus infection of host
cells greatly remodels the morphology of the ER and Golgi appa-
ratus, and some studies have shown that transfection and expres-
sion of the individual membrane-associated nonstructural pro-
teins (NSPs) alone can replicate this effect. In some cases, viral
replication or expression of 3A has been reported to cause an
inhibition of protein traffic through the secretory pathway, but in
some cases it does not. Whether a particular virus inhibits the
secretory pathway is of great importance in host antiviral defense,
as it would inhibit the secretion of inflammatory cytokines, anti-
viral interferons, and the cell surface expression of major histo-
compatibility complex (MHC) class I. Indeed, inhibition of the
secretory pathway often has been cited as a mechanism by which
picornaviruses evade host defense mechanisms.
Two independent studies showed that the 3A protein of CV
and PV blocked secretion by binding and inhibiting the function
of GBF1, the GTP exchange protein that controls the function of
Arf1, whereas the 3A proteins of HRV2, HRV14, encephalomyo-
carditis virus, FMDV, and hepatitis A virus did not (15, 16). How-
ever, subsequent studies showed HRV1A infection and overex-
pression of the HRV1A 3A protein did cause Golgi structure
fragmentation (17). Given these inconsistencies and the clinical
importance of HRV, we considered it important to comprehen-
sively investigate whether viral infection and expression of indi-
vidual HRV16 nonstructural proteins did indeed affect the secre-
tory pathway. We chose HRV16, as this is a well-characterized
serotype and themost frequently used in human clinical studies in
both asthma and COPD (18–21). To this end, we have transfected
each individual nonstructural HRV16 protein into HeLa cells and
determined their effect on morphological remodelling of the ER
and Golgi apparatus. We also have quantified their effect on the
secretory pathway bymeasuring the release of a Gaussia luciferase
(Gluc) reporter. Finally, we compared these results to Golgi appa-
ratus remodelling and luciferase secretion from HeLa cells in-
fected with whole HRV16 live virus and demonstrate significant
differences between these two techniques.
MATERIALS AND METHODS
Cell culture. The cervical epithelial HeLa Ohio (ECACC 93021013) and
HeLa H1 (ATCC CRL-1958) cell lines were maintained in exponential
growth in high-glucose Dulbecco’s modified Eagle medium (DMEM)
supplemented with glutamine, 1% sodium bicarbonate, 25 mM HEPES,
and 10% fetal bovine serum. The transfection of HeLa cells withmamma-
lian expression plasmids was performed using FuGENE HD transfection
reagent (Promega), with a 3.5:1 FuGENEHD-to-DNA ratio and doubling
the volume of transfection mix added per well compared to the manufac-
turer’s instructions. The HeLa Ohio cell line stably expressing Gluc was
created by transfection with the pCMV-GLuc 2 plasmid (New England
BioLabs) and selection with 1 mg/ml Geneticin-G418 (Invitrogen).
Plasmid construction. cDNA constructs for each HRV16 nonstruc-
tural protein (NSP) were made by PCR amplification using the following
primer pairs (each NSP cDNA was cloned into pRK5-Myc [Clontech]
using the restriction sites indicated below by standard molecular biology
techniques): Myc-HRV162A, 5=-TATGATGGATCCGGGCCTAGTGAC
ATGTATGTGC-3= (BamHI) and 5=-GCGCGCGAATTCTCATTGTTCT
TCAGCACAGTGAAAG-3= (EcoRI); Myc-HRV16 2B, 5=-GACGACGGA
TCCGGAATCACTGATTACATACACATGC-3= (BamHI) and 5=-CGCG
CGAATTCTCATTCTTTGTGTATATAAGTTAATTGAG-3=(EcoRI);Myc-
HRV16 2C, 5=-GCGCGCGGATCCTCAGATTCATGGCTCAAAAAATT
CAC-3= (BamHI) and 5=-GCGCGCGAATTCTCATTGGAAAATTGCAG
ACATGACATC-3= (EcoRI); Myc-HRV16 2BC, 5=-GACGACGGATCCGGA
ATCACTGATTACATACACATGC-3= (BamHI) and 5=-GCGCGCGAATTCT
CATTGGAAAATTGCAGACATGACATC-3=(EcoRI);Myc-HRV163A,5=-GA
CGACGGATCCGGGCCTATATCCATGGATAAACCC-3= (BamHI) and 5=-
GCGCGCGAATTCTCACTGTAGAGAGCAAAAGAGC-3= (EcoRI); Myc-
HRV16 3AB, 5=-GACGACGGATCCGGGCCTATATCCATGGATAAA
CCC-3= (BamHI) and 5=-GCGCGCGAATTCTCATTGAGCTACCACTC
TTCTCTCG-3= (EcoRI); Myc-HRV16 3C, 5=-GAGTGCGGATCCGGTC
CAGAAGAAGAATTTGGAATGTC-3= (BamHI) and 5=-GCGCGCGAATT
CTCATTGTTGTTCAGTGAAGTATGATCTC-3= (EcoRI); Myc-HRV16
3D, 5=-GACGACGGATCCGGCCAAATTCAAATCTCTAAACATG-3=
(BamHI) and 5=-GCGCTCGCGATCAGAATTTTTCATACCATTCATG
TCTTAG-3= (NruI). All of the pRK5-Myc-HRV16 constructs contained the
published HRV16 sequence (18) (GenBank accession no. L24917) and an
N-terminal Myc tag. The sequence identity and correct orientation of all in-
serts were verified by DNA sequencing.
HRV16 stock production and infections.HRV16 viral stocks (ATCC
VR-283) were produced by infecting HeLa H1 cells, and their titers were
determined bymeasuring the 50% tissue culture infectious dose (TCID50)
in HeLa Ohio cells.
HeLa Ohio cells were infected with HRV16 at a multiplicity of infec-
tion (MOI) of 1 or 20. Infections were synchronized by virus adsorption
on the cells for 1 h at room temperature, followed by one wash with
phosphate-buffered saline (PBS) and the addition of new media before
incubating the cells at 37°C for 2 to 24 h, as indicated.
Immunofluorescence microscopy. Cells grown on glass coverslips
were washed with PBS, fixed for 15 min with 4% formaldehyde, and
washed with PBS. After quenching residual formaldehyde with 0.1 M
glycine, cells were washed with PBS, permeabilized for 10 min at room
temperature with 0.1% Triton X-100, and then washed with PBS. After
blocking in 5% fetal bovine serum, cells sequentially were incubated with
primary and secondary antibodies diluted in 1% bovine serum albumin
(BSA). Apart from the calnexin antibody, which was incubated overnight
at 4°C, primary antibodies were incubated for 1 h at room temperature
and secondary antibodies were incubated for 45 min at room tempera-
ture. Cells were washed in PBS after each antibody incubation. Coverslips
were mounted in ProLong Gold antifade reagent (Invitrogen) and ana-
lyzed using an LSM 5 PASCAL laser scanning microscope (Carl Zeiss).
The following primary antibodies were used at the indicated dilution:
mouse anti-Myc tag (05-724; 1/500; Millipore), rabbit anti-calnexin
(2679S; 1/50; New England BioLabs), rabbit anti-Giantin (ab80864;
1/500; Abcam), mouse anti-GM130 (610822; 1/500; BD Pharmingen),
sheep anti-TGN46 (AHP500GT; 1/500; AbD Serotec), and rabbit anti-
HRV16 2C (this study; 1/500). Secondary antibodies were obtained from
Jackson ImmunoResearch (1/200).
Electronmicroscopy.One culture well of each HRV16-infected (3, 5,
and 7 h) and uninfected control HeLa cells was scraped and fixed with
2.5% glutaraldehyde in 0.05 M sodium cacodylate buffer (pH 7.2). Cells
were spun at 2,500 rpm (approximately 1,000 g) for 5min, resuspended
in agar, and spun to form a pellet. The pelleted cells were rinsed in caco-
dylate buffer and postfixed in buffered 1% osmium tetroxide. After a
water rinse, the samples were dehydrated by a graded (70 to 100%)meth-
anol series. Sample transition to 100% araldite was through 50:50 and
then 25:75 propylene oxide-aralditemixtures. Ultrathin (70-nm) sections
of araldite-embedded samples were stained with uranyl acetate and
lead citrate and then examined with a transmission electron microscope
(Hitachi H7000).
Flow cytometry. HeLa Ohio cells were infected with HRV16 at an
MOI of 20 for 7 h. After washing with PBS, cells were detached with
Accutase (Life Technologies), washed a further time, and stained with a
fixable near-IR live/dead discriminator (Life Technologies). Cells were
fixed with 1% formaldehyde, washed, and incubated with 1% human
serum (HS) overnight. Following permeabilization with 0.5% sapo-
nin-1% HS in PBS, cells were either stained with rabbit anti-HRV16 2C
antibody (1/500; this study) or purified rabbit IgG control (1/500; R&D
Mousnier et al.
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Systems). Cells were visualizedwith donkey anti-rabbit Alexa 488 second-
ary antibody (1/200; Jackson ImmunoResearch). Photomultiplier tube
(PMT) voltages were adjusted after standardized cytometer setup and
tracking (CST) checks minimizing the spectral overlap to increase data
precision. Cells were measured on a Becton Dickinson Fortessa LSR-
SORP equipped with various lasers (20mWat 355 nm, 50mWat 405 nm,
50 mW at 488 nm, 50 mW at 561 nm, and 20 mW at 633 nm) and an
ND1.0 filter in front of the forward scatter (FSC) photodiode and ana-
lyzed with FlowJo software (TreeStar).
Secretion assay. For transfection experiments, HeLa Ohio cells were
cotransfected in 24-well plates with pCMV-GLuc 2- and pRK5-Myc-de-
rived plasmids at a ratio of 1:3 for 24 h. For infection experiments, HeLa
Ohio cells stably expressing Gaussia luciferase (HeLa-Gluc) were plated at
a density of 0.2 106 cells per well in a 24-well plate, and each time point
was performed in triplicate. Cells were infected with HRV16 at anMOI of
20 for 1 h at room temperature and then washed in PBS before adding
fresh medium and starting a 7-h time course. During the infection time
course, culture mediumwas removed and replaced every 30min and cells
collected every 1 h. As controls, HeLa-Gluc cells either were not infected
with virus orwere not infected but treatedwith brefeldinA (BFA) at a final
concentration of 5 g/ml. To determine the Gluc activity in the cells, the
wells were washed with PBS and the cells lysed in 250 l of luciferase cell
lysis buffer (B3321; New England BioLabs). Gluc secreted in the media
and remaining in the cells was assayed using the BioLuxGaussia luciferase
flex assay kit (E3308S; New England BioLabs) according to the manufac-
turer’s instructions. Luminescence was analyzed on a FLUOstar OMEGA
plate reader (BMG Labtech) as recommended. Each time point was de-
termined in triplicate, and the experiment was performed independently
three times.
Western blotting. Cells were lysed in Laemmli sample buffer, and
their DNA content was measured with a NanoDrop. An equivalent
amount of DNAwas loaded for each sample, and proteins were separated
by SDS-PAGE.After transfer to PVDFmembranes, proteinswere revealed
with a rabbit anti-HRV16 3A antiserum (produced for this study), a rabbit
anti--actin antibody (3662-100; Bio Vision), or a mouse anti-Myc tag
antibody (05-724; Millipore). Secondary antibodies were obtained from
Jackson ImmunoResearch.
Generation of antibodies.A29-amino-acid peptide corresponding to
the N terminus of HRV16 3A (GPISMDKPPPPAITDLLRSVRTPEVI
KYC) was synthesized and coupled to the carrier protein PPD, which had
previously been derivatized to the heterobifunctional cross-linker MBS
(Cambridge Research Biochemicals, United Kingdom). The peptide-PPD
conjugate was used to immunize two rabbits using standard protocols
(Covalab, France). A full-length cDNA sequence for HRV16 2C with an
N-terminal 6-His tag was codon optimized and cloned into the bacterial
expression plasmid pET-26b (Novagen) using the NdeI/XhoI sites. The
full-length 2C protein was expressed in Escherichia coli BL21(DE3) and
purified from inclusion bodies. The identity of the purified protein was
confirmed by peptide mass fingerprinting. Purified HRV16 2C protein
was used to immunize two rabbits using standard protocols (Covalab,
France). All antiserum titers were quantified by enzyme-linked immu-
nosorbent assay (ELISA), and their specificity was tested byWestern blot-
ting.
RESULTS
Transfected HRV16 nonstructural protein 2B induces endo-
plasmic reticulum aggregates. In order to assess the subcellular
localization of theHRV16 nonstructural proteins, each individual
proteinwas expressed inHeLa cells with anN-terminalMyc tag by
transfection. The expression of the proteins was verified byWest-
ern blotting with an anti-Myc antibody, revealing the expression
of all HRV16 nonstructural proteins apart from 2A (Fig. 1A).
Transfection with 2A appeared to induce substantial cell death;
consequently, protein expression probably fell below the detec-
tion limit. Expression of 3D produced the expected 54-kDa pro-
tein, but a 14-kDa N-terminal fragment also clearly was detected.
The expression levels of each nonstructural protein varied widely
despite their best efforts to transfect as efficiently as possible.
Moreover, expression levels of 3A and 3AB were particularly high
and even higher than their cellular levels following infection at an
MOI of 1 or 20 (Fig. 1B).
The analysis of the transfected cells by immunofluorescence
microscopy with an anti-Myc antibody revealed that the viral
nonstructural proteins 2A, 3C, and 3Dhad a diffuse localization in
the cytoplasm and the nucleus, with 2A and 3C accumulating
particularly in the nucleus of transfected cells (Fig. 2 and 3). How-
ever, contrary to the viral polymerase 3D, very few cells expressed
the viral proteases 2A and 3C, and most cells detached from the
coverslips, suggesting that the expression of 2A or 3C was cyto-
pathic. Therefore, 2A and 3C were not investigated further.
The nonstructural proteins 2B, 2C, 2BC, 3A, and 3AB had cy-
toplasmic localization and colocalized to various extents with the
ER marker calnexin (Fig. 3). In particular, 2B had a reticular dis-
tribution but also formed large aggregates and fine vesicles in the
cytoplasm, both of which colocalized with calnexin staining, indi-
cating that 2B localized to the ER and was able to redistribute it
from a reticular pattern in control cells (transfected with the
empty vector or the GFP cDNA) to 2B-stained aggregates. 2C
displayed a reticular localization but also formed vesicles, often
FIG 1 (A) Analysis of the ectopic expression ofHRV16 nonstructural proteins
byWestern blotting. HeLa cells were transfected with the indicated pRK5-Myc
constructs or the empty vector (). Cells then were lysed in Laemmli sample
buffer 24 h posttransfection, and the DNA content of the samples was assessed
by NanoDrop measurement. The same amount of DNA was loaded for each
sample, and the proteins were revealed by Western blotting with an anti-Myc
antibody. The position of the proteins is indicated on the right, together with
their predicted molecular mass in kDa. (B) HRV16 3A and 3AB are expressed
at higher levels from transfected cells than from infected cells. HeLa Ohio cells
were infected for 24 h with HRV16 at the indicated MOI, transfected with
cDNA constructs allowing the expression of N-terminal Myc tagged HRV16
3A or 3AB, or left untreated (cells). Cells then were lysed in Laemmli sample
buffer, and the DNA content of the samples was assessed by NanoDrop mea-
surement. The same amount of DNA was loaded for each sample, and the 3A
protein and -actin loading control were revealed by Western blotting with
anti-3A and anti--actin antibodies, respectively.
Golgi Apparatus Fragmentation by Rhinovirus
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but not always located near the nuclear envelope. The reticular
distribution of 2C partially colocalized with the ER marker cal-
nexin. As for 2B, the 2BC protein also displayed a reticular distri-
bution in addition to aggregates, which partially colocalized with
calnexin. 3A presented a reticular and nuclear envelope staining
which also colocalized with calnexin, in addition to a more punc-
tate staining distributed throughout the cell cytoplasm which did
not colocalize with calnexin. The 3AB precursor, on the other
hand, only showed an ER-matching reticular and nuclear enve-
lope staining.
Transfected HRV16 nonstructural protein 3A and 3AB dis-
rupt the Golgi structure.To test if theHRV16 nonstructural pro-
teins colocalized with or had an effect on the Golgi apparatus
architecture, HeLa cells transfected with the Myc-tagged HRV16
nonstructural protein constructs were costained for the cis- and
medial-Golgi marker Giantin, together with the Myc tag (Fig. 4).
Strikingly, the Giantin distribution patternwas strongly disrupted
upon 3A expression, from a compact localization in control cells
transfected with GFP or the empty vector to a much more dis-
persed localization with a reticular distribution resembling that of
typical ER staining. Together with the colocalization with the ER
marker calnexin, this indicates that HRV16 3A disrupts the Golgi
structure, probably by interfering with vesicular trafficking be-
tween the ER and the Golgi apparatus, thereby redistributing the
Golgi components into the ER compartment. Some Golgi appa-
ratus dispersion also was observed in 3AB-transfected cells, al-
though this effect was less pronounced than that with the 3A con-
struct, suggesting that the 3B fusion interferes with the ability of
3A to affect trafficking. Finally, 2B also mildly disrupted the Golgi
structure in some of the transfected cells. SinceGolgi structure can
be variable in individual cells, we carefully quantified the Golgi
dispersal phenotype. In 3 independent experiments, we con-
firmed that expression of 3A and, to a lesser extent, 3AB caused
significant dispersal of theGolgi components (P 0.0001 andP
0.001, respectively), whereas the effect of 2B expression did not
reach significance (Fig. 5). The expression of 2C, 2BC, and 3D did
not significantly affect the Golgi structure (Fig. 4 and 5).
Transfected HRV16 nonstructural proteins 2B, 3A, and 3AB
inhibit cellular secretion. As 2B induced ER aggregates and 3A
and 3AB induced Golgi apparatus disruption, we evaluated if
these events had any consequences on cellular protein secretion.
We analyzed the secretion of a reporter protein, Gluc, from the
copepod Gaussia princeps, which contains a native signal peptide
at the N terminus that allows it to be trafficked through the clas-
sical secretory pathway (Fig. 6). A Gluc cDNA expression plasmid
was cotransfected in HeLa cells together with the HRV16 non-
structural protein cDNA constructs. To ensure Gluc-expressing
cells also expressed the transfected HRV16 NSP, cells were
cotransfected with amixture of 25%pCMV-Gluc and 75%pRK5-
Myc-NSP plasmids. Twenty-four h after transfection, Gluc secre-
tion over a 2-h period was analyzed by measuring Gluc activity in
the media and the cell lysates. The percentage of Gluc secretion
over 2 h, which represents the Gluc activity in the media divided
by the total Gluc activity found in the media and cell lysates, was
significantly inhibited in 2B- and 3A-transfected cells and, to a
lesser extent, in 3AB-transfected cells compared to control cells
transfected with GFP or the empty vector. The inhibition by 2B
was significant despite relatively low levels of expression of the
protein (Fig. 1A). This result indicates that 2B, 3A, and, to some
degree, 3AB disrupts cellular protein secretion, in line with the
observation that these proteins affect the ER or Golgi structure.
The expression of 2C, 2BC, and 3D did not significantly affect
Gluc secretion, although there was a trend for inhibition by 2BC.
However, for 2BC, we cannot exclude that the small effect onGluc
secretion is due to its low expression levels (Fig. 1A).
HRV16 infection disrupts the Golgi structure. In order to
evaluate the effect over time of HRV16 infection on the Golgi
structure, we infected HeLa cells for different periods of time and
monitored infection and the Golgi structure by immunofluores-
cencewith an anti-HRV16 2C antibody, an anti-GM130 antibody,
and an anti-TGN46 antibody, respectively (Fig. 7 and 8). As a
control for Golgi structure dispersal, we treated cells with brefel-
din A and stained them with anti-GM-130 or anti-TGN46. To
have a maximal number of synchronously infected cells, an MOI
of 20 was chosen. However, at this MOI, a noticeable cytopathic
effect (CPE) could be observed between 6 and 7 h of infection. As
a marker of viral replication, cells staining positive for 2C expres-
sion started to be observed from 3 h postinfection (see Fig. 11).
From this time point, cells expressing the highest level of 2C al-
ready displayed some Golgi structure dispersion, compared to the
uninfected control cells, for both the cis-Golgi marker (GM-130)
and the trans-Golgi marker (TGN46). This effect increased as the
infection time and 2C expression levels progressed, as evidenced
by the quantification of theGolgi structure in 2C-positive infected
cells from3 independent experiments atMOIs of 20 and 1 (Fig. 9).
These results indicate that HRV16 infection effectively disrupts
the Golgi structure, leading to fragmentation of the Golgi struc-
ture into dispersed structures throughout the cell cytoplasm, with
86.7% of cells that were positive for 2C having dispersed Golgi
structures at 7 hpi (MOI, 20) and 93.3% at 20 hpi (MOI, 1). This
level of Golgi dispersal was quantitatively equivalent to treatment
with BFA. We confirmed that the morphological disruption
caused by viral replication by electron microscopy (Fig. 10). In
infected cells, we observed frequent swollen single-membrane
vesicles andmultivesicular bodies and, by 7 hpi, the appearance of
many electron-dense structures, probably condensed mitochon-
dria.
FIG 2 Localization of HRV16 proteases in transfected HeLa cells. HeLa Ohio
cells were transfected with cDNA constructs allowing the expression of the
HRV16 proteases 2A and 3C with an N-terminal Myc tag. Cells then were
stained by immunofluorescence with an anti-Myc antibody.
Mousnier et al.
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FIG 3 Effect of rhinovirus HRV16 nonstructural protein expression on the endoplasmic reticulum. HeLa Ohio cells were transfected with cDNA constructs
allowing the expression of the indicated HRV16 nonstructural proteins or the GFP control with an N-terminal Myc tag. The nonstructural proteins and the
endoplasmic reticulum marker calnexin were stained by immunofluorescence with anti-Myc and anti-calnexin antibodies, respectively, revealing partial
colocalization of the nonstructural proteins 2C, 3A, and 3AB with calnexin and redistribution of the endoplasmic reticulummarker to 2B- and 2BC-containing
aggregates. Images are single confocal 0.37-m optical sections. Scale bar, 10 m.
Golgi Apparatus Fragmentation by Rhinovirus
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FIG 4 Effect of rhinovirus HRV16 nonstructural protein expression on the Golgi structure. HeLaOhio cells were transfected with cDNA constructs allowing the
expression of the indicated HRV16 nonstructural proteins or the GFP control with an N-terminal Myc tag. The nonstructural proteins and the Golgi marker
Giantin were stained by immunofluorescence with anti-Myc and anti-Giantin antibodies, respectively, revealing some Golgi structure disruption upon expres-
sion of the nonstructural proteins 3A, 3AB, and, to a lesser extent, 2B compared to the compact Golgi structure observed in GFP-transfected cells. Images are
single confocal 0.37-m optical sections. Scale bar, 10 m.
Mousnier et al.
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HRV16 infection does not block cellular protein secretion.
Since HRV16 infection induced Golgi structure dispersion, we
analyzed if this functionally affected cellular protein secretion us-
ing the Gluc reporter secretion assay. As we found that transient
transfection of cDNA plasmids had an inhibitory effect on infec-
tion, we established aHeLa cell line stably expressing Gluc (HeLa-
Gluc) and used it for infection with HRV16 at an MOI of 20. We
analyzed 2C expression following an infection time course as a
marker for viral replication.HeLa cells were infectedwithHRV16,
and 2C expression over a 7-h time course was detected by immu-
nofluorescence confocalmicroscopy (Fig. 11A). The percentage of
cells with detectable 2C expression by confocal microscopy was
quantified by manually counting cells at various time points from
7 independent experiments. 2C was first detectable at 3 hpi and
reached a maximum of 64.7% (4.9 SEM; n 	 7) by 7 hpi (Fig.
11B). The infection time course also was confirmed by Western
blotting of extracts from infected cells and detection of 2C and
2BC with an anti-2C antibody (Fig. 11C). As an alternative tech-
nique, we quantified 2C-positive cells by flow cytometry and
found that at 7 hpi, 83.6%of the cells had detectable 2C expression
(Fig. 11D), suggesting that the determination of viral replication
by immunofluorescence microscopy is an underestimate. To as-
sess the impact of viral replication on protein secretion, we in-
fected HeLa-Gluc cells at an MOI of 20 and collected the culture
medium at 30-min intervals and cell lysates at 1-h intervals up to 7
hpi. The Gluc activity in the culture medium and cell lysates sub-
sequently was measured. As controls, we measured levels of Gluc
in cell lysates and culture medium from uninfected HeLa-Gluc
cells and from cells treated with BFA. In parallel, we quantified 2C
expression in cells by immunofluorescence with an anti-2C anti-
body to confirm infection. Over the 7-h time course, HRV16 rep-
lication did not significantly affect Gluc secretion compared to the
uninfected control cells (when assessed by a two-way analysis of
variance [ANOVA] with a Bonferroni posttest analysis), although
between 6 and 7 hpi there was a trend to a reduced rate of Gluc
secretion (Fig. 12). At 6 hpi, 64.0%of the cells stain positive for 2C
(Fig. 11B) and 80.6% of 2C-positive cells have dispersed Golgi
structures (Fig. 9); thus, at least 51.6% of the cells in the culture at
this time point will have disrupted Golgi structures, although
based on flow cytometry, this is likely to be an underestimate.
Nevertheless, at 6 hpi there is no significant inhibition or reduc-
tion in Gluc secretion. Analysis of Gluc activity in the cell lysates
clearly showed that levels of the marker remained constant over
the 7-h time course, and that levels were comparable in infected
and uninfected cells. Treatment of the HeLa-Gluc cell line with
BFA clearly and completely inhibited Gluc secretion and resulted
in Gluc accumulation in the cell lysate. Together, these results
indicate that HRV16 infection leads to the dispersion of the Golgi
but does not significantly block cellular protein secretion.
DISCUSSION
In this study, we have sought to characterize the subcellular local-
ization of individually transfected HRV16 proteins and their in-
fluence on the structure and function of the secretory pathway and
to compare these effects to those of HRV16-infected cells.
We have shown that individual expression of HRV16 2B in-
duced ER aggregates and slightly disrupted the Golgi structure,
while expression of 3A and, to a lesser extent, 3AB, which also
FIG 5 Transfected HRV16 3A and 3AB significantly disrupt the Golgi struc-
ture. HeLa Ohio cells were transfected with cDNA constructs allowing the
expression of the indicated HRV16 nonstructural proteins or the GFP control
with anN-terminalMyc tag. The nonstructural proteins and the Golgi marker
Giantin were stained by immunofluorescence with anti-Myc and anti-Giantin
antibodies, respectively. For each condition, the Golgi structure of 100 trans-
fected cells was assessed and classified in one of the three categories depicted in
panel A: compact, extended, and dispersed. For control vector-transfected
cells, 100 random cells were evaluated. The mean number of cells in each
category from 3 independent experiments is represented in panel B. Error bars
represent the standard errors of the means (SEM). Results were analyzed with
GraphPad Prism 6 software, using a two-way ANOVA followed by Dunnett’s
multiple-comparison posttest. Significant differences compared to the GFP-
transfected control are marked.
FIG 6 Transfected HRV16 2B and 3A significantly disrupt secretion of the
Gaussia luciferase reporter. HeLa Ohio cells were cotransfected with con-
structs allowing the expression of the naturally secreted Gaussia luciferase
(Gluc) and the indicated HRV16 nonstructural proteins or the GFP control
with an N-terminal Myc tag. After 24 h of transfection, the cell medium was
replaced and theGluc was allowed to be secreted for 2 h. TheGluc activity then
was measured in the medium and cell lysates, allowing the calculation of the
percentage of secreted Gluc, which represents the Gluc activity in the media
divided by the total Gluc activity present in the media and lysates combined.
The data represent the mean percentages of Gluc secreted from 3 independent
experiments. Error bars represent the standard errors of the means (SEM).
Results were analyzed with GraphPad Prism 6 software, using one-way
ANOVA followed by Dunnett’s multiple-comparison posttest. Significant dif-
ferences compared to the GFP-transfected control are marked.
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FIG 7 Effect of HRV16 infection on the cis-Golgi structure. HeLa Ohio cells were uninfected or infected with HRV16 at an MOI of 20 for the indicated periods
of time. The nonstructural protein 2C and the Golgi marker GM130 were stained by immunofluorescence, revealing Golgi structure disruption in infected
(2C-positive) cells compared to the compact Golgi structure observed in uninfected cells. As a control, HeLa cells were left untreated or treated with BFA to
disrupt the Golgi structure. Images are single confocal 0.37-m optical sections. Scale bar, 10 m.
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colocalized with the ER, induced significant Golgi structure dis-
persion. Expression of 2B, 3A, and, to a lesser extent, 3AB signif-
icantly inhibited cellular protein secretion, as evidenced by the
reduction of the secretion of the Gluc reporter. The other non-
structural proteins did not significantly affect the ER or Golgi
structure or Gluc secretion. These results show that inhibition of
secretion is not directly related to the level of NSP expression (3A
and 3AB being very high and 2B being very low) and not directly
FIG 8 HRV16 infection disrupts the trans-Golgi network (TGN) structure. HeLa Ohio cells were uninfected or infected with HRV16 at an MOI of 20 for the
indicated periods of time. The nonstructural protein 2C and the trans-Golgi network marker TGN46 were stained by immunofluorescence, revealing the
disruption of the TGN structure in 2C-stained infected cells compared to the compact Golgi structure observed in uninfected cells. As a control, HeLa cells were
left untreated or treated with BFA to disrupt the Golgi structure. Images are single confocal 0.37-m optical sections. Scale bar, 10 m.
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related to the degree of Golgi dispersal (3A and 3AB being signif-
icant and 2B less pronounced). Our results on the effect of HRV16
3A are consistent with the effect reported for HRV1A 3A (17),
which is phylogenetically closely related toHRV16 (22).However,
our data are clearly different from those of previous studies ex-
pressing 3A fromHRV14 (15, 16, 23) andHRV2 (16) that showed
that these proteins did not cause Golgi disruption or secretion
inhibition. Similarly, studies on FMDV 3A showed that it too did
not cause a secretion block (24). However, overexpression of 3A
from other picornaviruses, such as PV (15, 16, 25–28) or CV (16,
23, 29), did block cellular protein secretion. The published evi-
dence for a role for 2B and 2C in Golgi structure disruption also is
conflicting. For CV, 2B and 2BC expression has been shown to
cause a mild secretion inhibition without disrupting the Golgi
structure (23) or a profound block in protein secretion (30). PV
2B has been shown to localize to what appeared to be intact Golgi
structures but also caused a secretion block (25), whereas other
studies reported Golgi structure disruption upon PV 2B expres-
sion (31). Some studies showed that PV 2C caused major remod-
elling of the Golgi structure (32) with no effect on protein secre-
tion (25) or no Golgi structure association at all for FMDV 2C
(33). The expression of FMDV 2BC or 2B and 2C together did
block secretion (24, 34), and in a yeast model system (35), over-
expression of 2BC caused a clear block in secretion and induced
membrane proliferation. Finally, it has been shown recently that
FMDV 3C is capable of causing Golgi fragmentation and blocking
secretion (36). Therefore, the literature on the effect of picornavi-
rus NSPs on the protein secretory pathway is abundant but not
always consistent. The lack of consistency may be due to genuine
differences between viruses, in expression of individual NSPs, the
FIG 9 HRV16 infection significantly disrupts the Golgi structure. HeLa Ohio
cells were uninfected or infected with HRV16 at the indicated multiplicity of
infection (MOI) and for the indicated periods of time. Treatment with BFA
was used as a control. The nonstructural protein 2C and the Golgi marker
GM130 were stained by immunofluorescence. At a time point when infected
cells could be detected by 2C staining, the Golgi structure of 100 infected
(2C-positive) cells was assessed and classified in one of three categories, as
depicted in Fig. 5A. Otherwise (for uninfected cells or cell infected for 2 h), 100
random cells were evaluated. Results represent the mean number of cells in
each category from 3 independent experiments. Error bars represent the stan-
dard errors of the means (SEM). Results were analyzed with GraphPad Prism
6 software, using a two-way ANOVA followed byDunnett’s multiple-compar-
ison posttest. Significant differences compared to the uninfected control are
marked.
FIG 10 Electron microscopy of HRV16-infected HeLa cells. HeLa cells were infected with HRV16 at an MOI of 20 for 3, 5, or 7 h. In the uninfected cell, stacks
of vesicular structures reminiscent of Golgi cisternae are apparent at high power (black arrowheads); however, in infected cells there are frequent swollen
single-membrane vesicles (black arrowheads), and numerous multivesicular bodies (white arrowheads) are apparent in the cytoplasm. By 7 hpi, there are
numerous electron-dense vesicular structures apparent which possibly are condensed mitochondria. Boxes represent the areas seen in the high-power-magni-
fication images. The nucleus (Nu) is indicated at low power. Scale bars, 2.0 m.
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host cell line, and the type of assay or whether the NSP is tagged or
not and perhaps even whether the tag is N or C terminal. In our
experiments, we found highly variable levels of expression of the
different NSPs when transfected into HeLa cells. 3A, 3AB, and 3D
expressed at high levels, 2C and 3C to intermediate levels, 2B and
2BC expressed very poorly, and 2A was hardly detectable. How-
ever, despite its low level of expression, 2B caused a significant
inhibition of protein secretion. Our studies comparing all of the
NSPs in the same system show how difficult it is to make quanti-
tative comparisons between experimental studies and possibly ex-
plains why the literature is so hard to reconcile on this topic. By
comparison, there are relatively few studies looking at the block in
protein secretion caused by viral infection and replication. There
appears to be a complete block by PV (25) but only a partial block
by CV (37), and there are several reports showing cytokine and
chemokine secretion from CV-infected cells (38–40).
Given our concerns about studying the effects of individual
NSPs on the secretory pathway, we decided to analyze the effect of
HRV16 infection. We optimized an MOI and time course to give
us as synchronous and uniform an infection as possible, and we
found that over this time course viral replication led to a substan-
tial dispersion of the Golgi structure but did not significantly
block or reduce protein secretion. After 6 hpi, therewas a trend for
a reduction in the rate of Gluc secretion, although not a complete
inhibition, and this corresponded with the onset of a CPE. The
observation that infected and uninfected cells produced equiva-
lent amounts of Gluc protein over the 7-h time course (medium
plus cell lysate) suggests that there was not a noticeable translation
shutoff of Gluc mRNA following infection. The Golgi structure
fragmentationwe observed is consistent with themany previously
cited reports. It is well established that the infection of cells with
picornaviruses induces dramatic rearrangements of membranes
of the secretory pathway into double membrane-bound vesicles
upon which viral replication complexes are thought to form, al-
though the exact origin of these replication complexes still is un-
clear. Our electron microscopy (EM) studies with HRV16 do not
reveal quite such dramatic membrane remodelling as that de-
scribed for PV. We observed an increase in swollen single-mem-
brane vesicles and multivesicular bodies and, by 7 hpi, frequent
electron-dense structures of unknown origin but reminiscent of
condensedmitochondria. There is evidence to suggest that PV and
CV form replication complexes by modifying COPI vesicles
through interference with GBF1/Arf1 (16, 41–46), and this is con-
sistent with BFA inhibiting the replication of these picornaviruses.
FIG 11 Time course of 2C expression following infection. HeLa cells were infected with HRV16 for various times. (A) 2C expression was detected by staining
with an anti-2C antibody and immunofluorescence confocal microscopy. (B) Infected HeLa cells were analyzed by immunofluorescence confocal microscopy,
and the percentage of cells staining positive for HRV16 2C was determined by manual cell counting. The results are the means  SEM from 7 independent
experiments. (C) HeLa cells were infected with HRV16, and cell lysates were prepared 0 to 7 hpi. Lysates were analyzed by SDS-PAGE followed by Western
blotting, and 2C and 2BC were revealed by staining with an anti-2C antibody. The blot also was stained with anti--actin as a loading control. (D) HeLa cells at
7 hpi with HRV16 at an MOI of 20 were fixed and stained with anti-HRV16 2C and analyzed by flow cytometry. The gray filled curve represents a preimmune
rabbit IgG control, and the red curve represents the cells stained with anti-HRV16 2C antibody. A total of 83.6% of the cells were gated as positive for 2C
expression.
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However, there are suggestions that replication complexes are de-
rived from COPII-coated vesicles at ER exit sites (47, 48), and
other evidence suggests they resemble autophagosomes (49, 50).
However, neither COPII nor autophagosome formation is inhib-
ited by BFA, which is known to be a potent inhibitor of PV, CV,
and HRV replication, although not of all picornaviruses (51).
Therefore, formation of picornavirus replication complexes is not
clearly understood at present, and further investigations are re-
quired. Much effort has been made to identify interactions be-
tween picornaviruses and the host cell that can provide a mecha-
nistic understanding of how the virus induces these structural
changes and their significance for viral replication and the host
antiviral response. Most work has focused on the membrane-as-
sociated viral proteins 2B, 2C, 3A, and their precursors 2BC and
3AB, often when transfected and expressed individually. A num-
ber of host proteins have been implicated in viral RNA translation
and replication (52) and in formation of the replication complex,
including Arf1 and its GTP exchanger GBF1 (13, 16, 41–43, 53),
PI4KIII (45, 54, 55), ACBD3 (54, 56), VCP (57), and OSBP (58,
59). Inhibitors of these pathways also are known to inhibit viral
replication (55, 58, 60), confirming their importance and the role
of the secretory pathway in the host-virus interaction. However, it
appears that Golgi fragmentation is not the cause of the protein
secretion block seen with PV, and it is proposed that these phe-
nomena are independent of one another (61). Our data also show
that for HRV16, Golgi fragmentation and secretion likely are in-
dependent phenomena.
The absence of a significant cellular protein secretion defect in
infected cells is consistent with previously published reports on
HRV-infected human bronchial epithelial cells and studies in pa-
tients showing that infected cells can secrete a wide range of cyto-
kines, chemokines, and interferons and can upregulateMHC class
I (62–70). Comparison between different HRV strains has shown
that HRV16 and HRV1A are the most effective at inducing cyto-
kine secretion (64). Although there is evidence for some picorna-
viruses that remodelling of the secretory pathway inhibits protein
trafficking, our data, together with available evidence, suggest that
HRV, unlike PV and CV, does not cause a secretion block. The
ability of a virus to block cellular protein secretion or not has
important implications for the host response to viral infection, as
an inability to secrete inflammatory cytokines and interferons and
to effectively traffic MHC class I to the plasma membrane would
severely impair the host’s ability to mount an effective antiviral
response. For HRV, this is particularly important. Much effort is
going into trying to understand why people with chronic respira-
tory diseases, such as asthma, COPD, or cystic fibrosis, appear to
have an exaggerated response to this virus, andmuch of this effort
is being directed at studying the cytokine, chemokine, and inter-
feron responses of the epithelial cell to infection. Whether or not
HRV blocks secretion from infected epithelial cells would be of
major importance to our understanding of exacerbations of air-
way diseases and for our prospects of discovering effective reme-
dies.
Our experiments with transfected HRV16 3A indicate that this
nonstructural protein disrupts the Golgi structure and inhibits
cellular protein secretion, whereas our infection experiments in-
dicate that infection with the whole virus disrupts only the Golgi
structure and does not inhibit cellular protein secretion. This sug-
gests that studies based on the isolated expression of individual
nonstructural picornaviral proteins are unlikely to reflect the
complexity of the changes occurring during an infection, as pro-
posed by others (61).
The observation that HRV16 infection leads to the dispersion
of the Golgi structure but does not block cellular protein secretion
raises several unresolved questions. First, picornaviruses disrupt
the Golgi structure by a mechanism that is thought to act through
the 3Aprotein interactingwithGBF1, although it is not clear if this
results in activation or inhibition of Arf1. BFA also fragments the
Golgi structure by inhibiting Arf1, yet it is a potent inhibitor of
viral replication (13, 16, 41, 71). What is the mechanistic signifi-
cance of Golgi structure fragmentation in picornaviral replica-
tion?Moreover, from a cell biology perspective, the fact that HRV
causes a dramatic fragmentation of the Golgi structure without
blocking secretion is unexpected. Golgi structure fragmentation is
observed in normal cells duringmitosis (72) or as a result of DNA
damage (73) through phosphorylation of GOLPH3, which is a
PtdIns(4)P-binding protein. DNA damage also can induce senes-
cence, and Golgi structure fragmentation also is observed in se-
FIG 12 HRV16 infection does not block secretion of the Gaussia luciferase
reporter. HeLa Ohio cells stably expressing the naturally secreted Gaussia lu-
ciferase (HeLa-Gluc) were infected with HRV16 (red squares) at anMOI of 20
for 1 h, followed by culture for the indicated periods of time up to 7 h postin-
fection (Time hpi). As controls, HeLa-Gluc cells were uninfected (blue circles)
or uninfected but treated with BFA (green triangles). The cell culture medium
was removed and replaced every 30 min, and the cells were harvested at 1-h
intervals. The Gluc activity then was measured in the culture media and cell
lysates. The cumulative secretion over time is calculated by adding each suc-
cessive 30-min culturemedia sample to the previous total. Panel A shows Gluc
activity in the cell lysate, and panel B shows secreted Gluc activity in the cell
culturemedium. Each point represents themean relative light units (RLU) (
standard deviations) as a measure of Gluc activity from triplicate assay points
from3 independent experiments. Blue circles, uninfectedHeLa-Gluc controls;
red squares, HRV16-infected HeLa-Gluc cells; green triangles, BFA-treated
HeLa-Gluc cells. The cumulative Gluc secretion into the culturemedium from
infected and uninfected cells was not significantly different at any time point
(results were assessed with the GraphPad Prism 6 software using a two-way
ANOVA with Bonferroni posttest analysis).
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nescent cells (74). It is well known that the senescent phenotype is
characterized by enhanced protein secretion (75). Thus, although
Golgi fragmentation by HRV without blocking secretion is sur-
prising, this is not an unprecedented biological phenomenon, and
it confirms that there is still much to learn about how picornavi-
ruses manipulate the secretory pathway.
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